[The mechanisms of antagonistic action of prostaglandin E1 against As2O3-induced hypothermia].
D000527:Alprostadil; D000818:Animals; D001151:Arsenic / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D000077237:Arsenic Trioxide; D001152:Arsenicals; D005406:Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide / Q000494:pharmacology; D002395:Catecholamines / Q000037:antagonists & inhibitors; D018492:Dopamine Antagonists; D010134:Fenclonine / Q000494:pharmacology; D007035:Hypothermia / Q000139:chemically induced / Q000503:physiopathology*; D007211:Indoles / Q000037:antagonists & inhibitors; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D010087:Oxides; D011458:Prostaglandins E / Q000494:pharmacology*; D011817:Rabbits; D014443:Tyrosine / Q000494:pharmacology; D019805:alpha-Methyltyrosine
D001152:Arsenicals; D002395:Catecholamines; D018492:Dopamine Antagonists; D007211:Indoles; D008781:Methyltyrosines; D010087:Oxides; D011458:Prostaglandins E; D005406:Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; D014443:Tyrosine; D019805:alpha-Methyltyrosine; D000527:Alprostadil; D001151:Arsenic; D010134:Fenclonine; D000077237:Arsenic Trioxide; D008784:Methysergide